Melissa S Y Tee,Stephanie Watson
Melissa S Y Tee
Retinoblastoma vascular perfusion and intra-arterial chemotherapy cycle requirements [0.03%]
视网膜母细胞瘤血管灌注与动脉内化疗周期需求
Li-Anne S Lim,Lauren A Dalvin,David Ancona-Lezama et al.
Li-Anne S Lim et al.
Importance: Retinoblastoma is a life- and sight-threatening malignancy. Background: To assess the relationship between tumour perfusion...
Harry Yip,Sarmad Akkach,Robin Meusemann
Harry Yip
Reversibility of postoperative wipe-out following glaucoma filtering surgery [0.03%]
青光眼滤过手术术后无滤泡状态的可逆性研究
Linda Zheng,Sartaj Sandhu,David Wechsler
Linda Zheng
Matthew McCartney,Peter McCluskey,Sophia Zagora
Matthew McCartney
Importance: Inflammatory-mediated cystoid macular oedema (CMO) is the most common inflammatory-mediated threat to vision in non-infectious uveitis (NIU). Corticosteroid therapy is the cornerstone to the management of CMO ...
Determining patient preferences in a glaucoma service: A discrete choice experiment [0.03%]
定量化合物服务中的青光眼患者偏好：一种离散选择实验的方法
Thomas Chengxuan Lu,Blake Angell,Hamish Dunn et al.
Thomas Chengxuan Lu et al.
Importance: Patient perspectives are crucial in informing design of acceptable services. Background: This study determined patient pref...
Determining patient preferences in a glaucoma service: A discrete choice experiment [0.03%]
基于小梁切除术的青光眼患者偏好的离散选择实验研究
Thomas Chengxuan Lu,Blake Angell,Hamish Dunn et al.
Thomas Chengxuan Lu et al.
Importance: Patient perspectives are crucial in informing design of acceptable services. Background: This study determined patient pref...
The challenge of an adequate outcome in trials for genetic eye disease such as Leber hereditary optic neuropathy [0.03%]
遗传性眼病（如Leber遗传性视神经病变）临床试验结果评价的挑战
David A Mackey,Lisa S Kearns
David A Mackey